SCHEMBL6825774

SCHEMBL6825774

CCC(Cc1c(O)c2ccccc2oc1=O)C(=O)OC.CCCCOC(=O)C(CC)Cc1c(O)c2ccccc2oc1=O.CCCOC(=O)C(CC)Cc1c(O)c2ccccc2oc1=O.CCOC(=O)C(CC)Cc1c(O)c2ccccc2oc1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 1/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ NQO1 P15559 3/20 0.46
▸ VKORC1 Q9BQB6 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ LMNA P02545 2/20 0.43
▸ HTT P42858 1/20 0.43
▸ ABCB11 O95342 1/20 0.42
▸ TP53 P04637 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ PCSK7 Q16549 1/20 0.42
▸ GPR35 Q9HC97 1/20 0.42
▸ POLB P06746 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5106585 0.91 NQO1 (0.50) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5113026 0.89 NQO1 (0.52) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL6825738 0.88 ADORA3 (0.50) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5103349 0.87 ADORA3 (0.62) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5106166 0.87 NQO1 (0.58) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5112817 0.82 NQO1 (0.52) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5106631 0.80 NQO1 (0.54) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL1649931 0.78 ADORA3 (0.59) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL6825211 0.77 ADORA3 (0.56) ADORA3ALDH1A1NQO1VKORC1MEN1
SCHEMBL5113813 0.77 NQO1 (0.57) ADORA3ALDH1A1NQO1VKORC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1383756-A1 COUMARIN DERIVATIVES TO BE USED AS ANTICOAGULANTS Arxy Therapeutics (US) 2004-01-28 — — EP disclosed
WO-2002085882-A1 COUMARIN DERIVATIVES TO BE USED AS ANTICOAGULANTS ARXY THERAPEUTICS (US) 2002-10-31 — — WO disclosed
Send feedback